Spotlight on Aggressive Non-Hodgkin Lymphomas (NHL)
We invite you to learn more about:
- Treatment options for aggressive subtypes of non-Hodgkin lymphoma (NHL)
- CAR T-cell therapy for aggressive lymphomas
- Side-effect management
- Questions to ask your healthcare team about treatment options and quality of life issues
Jason Westin, MD, MS, FACP
Director, Lymphoma Clinical Research
Section Chief, Aggressive Lymphoma
Department of Lymphoma & Myeloma
The University of Texas at MD Anderson Cancer Center
Houston, TX
Program Support
Support for this program is provided by Bristol Myers Squibb, Eli Lilly and Company, Genmab US & AbbVie Inc., Incyte Corporation, Kite, A Gilead Company, Merck & Company, and MorphoSys US.
Resilience Through Progress: Slow Growing Non-Hodgkin Lymphoma (NHL)
We invite you to learn more about:
- How your NHL subtype determines treatment goals and strategies
- Navigating the uncertainty of a chronic disease
- New therapies on the horizon
- Methods to manage side effects
J.C. Villasboas B., MD
Assistant Professor, Medicine and Oncology
Mayo Clinic College of Medicine and Science
Consultant, Division of Hematology
Director, Mayo Clinic Immune Monitoring
Core Laboratory
Mayo Clinic
Rochester, MN
Program Support
Support for this program provided by Genentech, Inc. & Biogen and Kite, a Gilead Company.
Spotlight On T-Cell Lymphoma
We invite you to learn more about:
- Subtypes of T-cell lymphomas
- Current and emerging therapies for T-cell lymphomas
- Side-effect management
- Communicating effectively with your healthcare team
Neha Mehta-Shah, MD, MSCI
Associate Program Director
Hematology-Oncology Fellowship
Associate Professor of Medicine
Siteman Cancer Center
Washington University School of
Medicine in St. Louis
St. Louis, MO
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.
Spotlight On Mantle Cell Lymphoma
We invite you to learn more about:
- Latest treatment advances for mantle cell lymphoma
- Relapse management
- Quality-of-life and side-effect management
Tycel Phillips, MD
Associate Professor
Hematology-BMT
City of Hope National Cancer Center
Duarte, CA
Program Support
Support for this program provided by Kite, a Gilead Company and Eli Lilly and Company.
Spotlight On Hodgkin Lymphoma
We invite you to learn more about:
- Treatment advances for Hodgkin lymphoma
- Side-effect management
- Treatment options for relapsed/refractory patients
- Monitoring for long term and late effects
- The importance of discussing quality of life issues with your healthcare team
Jeremy Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.